Red Nucleus Acquires Bridge Medical Consulting

Red Nucleus Acquires COEUS

February 4, 2025

Healthcare Services

Red Nucleus, a global strategic partner to life sciences companies, has acquired COEUS, a market access consulting and communications firm. The deal augments Red Nucleus' market access capabilities—particularly payor outreach, HEOR, patient access, and commercialization support—strengthening services for pharmaceutical and biotech clients.

Red Nucleus Acquires Jupiter Life Science Consulting

September 12, 2022

Consulting

Red Nucleus, a Riverside-backed life sciences services platform, has acquired Jupiter Life Science Consulting, a boutique provider of market access and commercialization strategies for pharma, biotech, and medical device clients. The add-on expands Red Nucleus's commercial and market-access capabilities, bringing Jupiter's expertise in payer research, pricing and access strategy, and commercialization planning into the combined platform.

Red Nucleus (RN) / Riverside Acquire AlphaGroup Medical Communications

December 12, 2022

Healthcare Services

Red Nucleus (RN), a portfolio company of The Riverside Company, has acquired AlphaGroup Medical Communications, LLC as an add-on to RN's medical communications business unit. The acquisition expands RN's publications, medical affairs and HEOR/RWE capabilities and brings AlphaGroup's therapeutic expertise and scientific staff into the combined business.

Red Nucleus / Riverside Invests in Human Element Solutions (element H)

February 21, 2023

Healthcare Services

Red Nucleus (RN), backed by The Riverside Company, acquired Human Element Solutions, LLC (element H) in February 2023 as an add-on to the RN platform. The acquisition brings element H's meeting and event production, creative communications, video and digital content capabilities into RN's learning & development business to expand services for biotech, pharmaceutical and medical device customers.

THL Partners Acquires Majority Stake in Red Nucleus from The Riverside Company

October 17, 2024

Healthcare Services

THL Partners (Thomas H. Lee Partners) has made a majority investment in Red Nucleus, a Yardley, Pennsylvania-based provider of medical communications, market access, learning & development, and R&D support for the life sciences industry. The Riverside Company sold its investment in Red Nucleus; the deal closed October 17, 2024 and will support expansion of Red Nucleus’ commercialization services under new CEO Mike Menta and continued involvement from founder Ian Kelly.

Red Nucleus Acquires Medical Marketing Solutions Group (MMSG)

February 9, 2022

Healthcare Services

Red Nucleus, a Riverside-backed medical communications and scientific services provider, acquired Medical Marketing Solutions Group (MMSG) in February 2022 to expand its medical communications, publication planning, and conference management capabilities. The acquisition was completed as an add-on to the Red Nucleus platform, owned by The Riverside Company, broadening Red Nucleus’s therapeutic-area coverage and client relationships within biopharma.